Researchers said the analysis lays bare a ‘decades-long-failure’ to tackle the overweight and obesity epidemic ...

Popular semaglutide-based drugs used for weight loss may reduce chronic and acute pain, which could make them a promising ...

It’s hard to remember a time before Ozempic, Wegovy, and other injectable drugs referred to as GLP-1 receptor agonists (that ...

More than 48 million Americans 12 years or older had a substance use disorder in 2022, yet only 24 percent received treatment ...

A new study has shed light on the health risks faced by people who stop using weight-loss medications Ozempic or Wegovy.

Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...

With new weight-loss drugs hailed as ‘miracle’ medicines, Harriet Symonds explores whether their increasing popularity should ...

Weight-loss drugs Ozempic and Wegovy have become popular worldwide. Many people have also reported suffering some serious ...

Even when patients are aware of the risks, adherence to diet, exercise, and medication remains low—even among those who have ...

A manufacturer-funded study found a significant decrease in annual total medical costs in patients with overweight/obesity ...

The current pain caused by the high cost of the GLP-1 agonist anti-obesity drugs will pass. Prachi Patkee and other analysts ...

Are you ready to lose weight fast? Work with a weight loss clinic in Houston and embark on your weight loss journey with the ...